2027 Best Value Molecular Pharmacology Schools in the Middle Atlantic Region
[Molecular Pharmacology](/majors/biological-biomedical-sciences/pharmacology-and-toxicology/molecular-pharmacology/) is a field worth comparing on the balance of cost and outcomes. A high-value program keeps cost low while graduates go on to earn well.
To produce this 2027 ranking, College Factual evaluated 4 schools on the balance of cost and outcomes for molecular pharmacology students.
What’s on this page:
2027 Best Value Molecular Pharmacology Schools in the Middle Atlantic Region
If you want to know which schools deliver the best value for the molecular pharmacology degrees they offer, see the list below.
Best Value Molecular Pharmacology Schools
For return on investment in molecular pharmacology, no school beat Stony Brook University this year. Located in the suburb of Stony Brook, Stony Brook University is a very large public university. Expect in-state tuition and fees of around $10,931, with out-of-state students paying around $32,741. Students borrow a median of $20,537 to complete the molecular pharmacology program here. Soon after graduation, molecular pharmacology degree recipients from Stony Brook University generally make around $60,047. That is a strong return on a $20,537 median debt. Stony Brook University admits about 49% of applicants.
University At Buffalo came in at #2 on our 2027 list of the best value molecular pharmacology schools. Set in the suburb of Buffalo, University At Buffalo is a very large public institution. Students from in state pay about $10,936 in tuition and fees, while out-of-state students pay about $31,536. Molecular Pharmacology graduates carry a median of $23,503 in student loans. Soon after graduation, molecular pharmacology degree recipients from University At Buffalo generally make around $52,403. Weighed against typical debt, the earnings make a compelling case for value. University At Buffalo admits about 74% of applicants.
A rank of #3 makes Rutgers University New Brunswick one of the best values for molecular pharmacology. Rutgers University New Brunswick is a very large public school located in the city of New Brunswick. Students from in state pay about $17,929 in tuition and fees, with out-of-state students paying around $37,441. Students borrow a median of $25,120 to complete the molecular pharmacology program here. Molecular Pharmacology graduates of Rutgers University New Brunswick earn a median of $58,402 early in their careers. That is a strong return on a $25,120 median debt. Roughly 58% of applicants are accepted.
A rank of #4 makes Drexel University one of the best values for molecular pharmacology. Drexel University is a very large private not-for-profit school located in the city of Philadelphia. The average in-state cost of tuition and fees is $62,412. Molecular Pharmacology graduates carry a median of $28,838 in student loans. Molecular Pharmacology graduates of Drexel University earn a median of $67,556 early in their careers. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 79%.
Narrow Molecular Pharmacology Schools by State
More Molecular Pharmacology Rankings
View All Molecular Pharmacology Rankings >
Notes and References
The ranking above is published by College Factual (MF_RANKING_2025), 2027 edition. Schools are scored on the balance of cost (tuition and student debt) against student outcomes (post-graduation earnings) — a measure of return on investment, drawn primarily from the U.S. Department of Education (IPEDS and College Scorecard).
Ranking method: College Major Best Value · 4 schools evaluated.
*Averages shown above reflect the top 4 ranked schools only.
- The Integrated Postsecondary Education Data System (IPEDS) from the National Center for Education Statistics (NCES), a branch of the U.S. Department of Education (DOE), serves as the core of our data about colleges.
- Some other college data, including much of the graduate earnings data, comes from the U.S. Department of Education’s (College Scorecard).
More about our data sources and methodologies.
